1
|
Li X, Giuseppe Fenu N, Giles-Donovan N, Cochran S, Lucas M. Can Mn:PIN-PMN-PT piezocrystal replace hard piezoceramic in power ultrasonic devices? Ultrasonics 2024; 138:107257. [PMID: 38335919 DOI: 10.1016/j.ultras.2024.107257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Revised: 01/24/2024] [Accepted: 01/27/2024] [Indexed: 02/12/2024]
Abstract
Mn:PIN-PMN-PT piezocrystal is investigated to determine whether its enhanced energy density makes it a candidate transducer material for power ultrasonics applications. To this end, the electromechanical and vibrational characteristics of a simple configuration of a bolted Langevin transducer (BLT) and then an ultrasonic surgical device, both incorporating Mn:PIN-PMN-PT piezocrystal, are compared with the same transducer configurations incorporating a conventional hard PZT piezoceramic commonly used in high-power ultrasonic transducers. The material properties of Mn:PIN-PMN-PT are determined using a single sample characterisation technique and these are used in finite element analysis (FEA) to design and then fabricate the BLT and ultrasonic surgical device, tuned to the first and second longitudinal modes at 20 kHz respectively. FEA is similarly used for the hard PZT versions. It is found that the superior elastic compliance of Mn:PIN-PMN-PT results in a higher radial piezo-stack deformation than the hard PZT under ultrasonic excitation of the BLT. However, the resulting longitudinal displacement amplitude of the two BLTs and two ultrasonic surgical devices is found to be equal, despite the higher figure of merit (Qkeff2) of those incorporating Mn:PIN-PMN-PT. The electrical impedance is measured at increasing excitation levels to evaluate the quality factor, Q. It is found that damping in the BLT with hard PZT is negligibly affected in the excitation range considered; however, the BLT incorporating Mn:PIN-PMN-PT exhibits a large reduction in Q. These findings indicate that, for measurements in air, the advantages of the high figure of merit of the piezocrystal material are not realised in a high-power transducer due to significantly increased damping at high excitation levels. To compare the vibrational response of the two ultrasonic surgical devices, L-C electrical impedance matching was implemented to maximise the efficiency of energy transfer from the source to the transducer under load. Results suggest that similar responses occurred for the two surgical devices in cutting tests using a low strength bone mimic material. However, the Mn:PIN-PMN-PT device exhibited better performance in cutting through higher strength ex-vivo chicken femur.
Collapse
Affiliation(s)
- Xuan Li
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK
| | - Nicola Giuseppe Fenu
- Nami Surgical, 11 The Square, University Avenue, University of Glasgow, G12 8QQ, UK
| | - Nathan Giles-Donovan
- Department of Physics, University of California, Berkeley, CA 94720, USA; Material Sciences Division, Lawrence Berkeley National Lab, Berkeley, CA 94720, USA
| | - Sandy Cochran
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK
| | - Margaret Lucas
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK.
| |
Collapse
|
2
|
Ko SH, Radecki P, Belinky F, Bhiman JN, Meiring S, Kleynhans J, Amoako D, Guerra Canedo V, Lucas M, Kekana D, Martinson N, Lebina L, Everatt J, Tempia S, Bylund T, Rawi R, Kwong PD, Wolter N, von Gottberg A, Cohen C, Boritz EA. Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection. bioRxiv 2024:2024.01.05.574420. [PMID: 38313289 PMCID: PMC10836083 DOI: 10.1101/2024.01.05.574420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2024]
Abstract
Previous studies have linked the evolution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic variants to persistent infections in people with immunocompromising conditions1-4, but the evolutionary processes underlying these observations are incompletely understood. Here we used high-throughput, single-genome amplification and sequencing (HT-SGS) to obtain up to ~103 SARS-CoV-2 spike gene sequences in each of 184 respiratory samples from 22 people with HIV (PWH) and 25 people without HIV (PWOH). Twelve of 22 PWH had advanced HIV infection, defined by peripheral blood CD4 T cell counts (i.e., CD4 counts) <200 cells/μL. In PWOH and PWH with CD4 counts ≥200 cells/μL, most single-genome spike sequences in each person matched one haplotype that predominated throughout the infection. By contrast, people with advanced HIV showed elevated intra-host spike diversity with a median of 46 haplotypes per person (IQR 14-114). Higher intra-host spike diversity immediately after COVID-19 symptom onset predicted longer SARS-CoV-2 RNA shedding among PWH, and intra-host spike diversity at this timepoint was significantly higher in people with advanced HIV than in PWOH. Composition of spike sequence populations in people with advanced HIV fluctuated rapidly over time, with founder sequences often replaced by groups of new haplotypes. These population-level changes were associated with a high total burden of intra-host mutations and positive selection at functionally important residues. In several cases, delayed emergence of detectable serum binding to spike was associated with positive selection for presumptive antibody-escape mutations. Taken together, our findings show remarkable intra-host genetic diversity of SARS-CoV-2 in advanced HIV infection and suggest that adaptive intra-host SARS-CoV-2 evolution in this setting may contribute to the emergence of new variants of concern (VOCs).
Collapse
Affiliation(s)
- Sung Hee Ko
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Pierce Radecki
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Frida Belinky
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Jinal N. Bhiman
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
- SAMRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Susan Meiring
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
| | - Jackie Kleynhans
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
- School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Daniel Amoako
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
- Department of Integrative Biology and Bioinformatics, College of Biological Sciences, University of Guelph, Ontario, Canada
| | - Vanessa Guerra Canedo
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Margaret Lucas
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Dikeledi Kekana
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
| | - Neil Martinson
- Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
- Johns Hopkins University, Center for TB Research, Baltimore, MD 21218, USA
| | - Limakatso Lebina
- Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
| | - Josie Everatt
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
| | - Stefano Tempia
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
- School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Tatsiana Bylund
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Reda Rawi
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Peter D. Kwong
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | - Nicole Wolter
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
- School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Anne von Gottberg
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
- School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Cheryl Cohen
- National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa
- School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Eli A. Boritz
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| |
Collapse
|
3
|
Yao G, Wu F, Lucas M, Zheng L, Wang C, Gu H. Effect of longitudinal-bending elliptical ultrasonic vibration assistance on electrosurgical cutting and hemostasis. Ultrasonics 2023; 135:107113. [PMID: 37517346 DOI: 10.1016/j.ultras.2023.107113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2022] [Revised: 06/24/2023] [Accepted: 07/18/2023] [Indexed: 08/01/2023]
Abstract
Electrosurgical devices are widely used for tissue cutting and hemostasis in minimally invasive surgery (MIS) for their high precision and low trauma. However, tissue adhesion and the resulting thermal injury can cause infection and impede the wound-healing process. This paper proposes a longitudinal-bending elliptical ultrasonic vibration-assisted (EUV-A) electrosurgical cutting system that incorporates an ultrasonic vibration in the direction of the cut by introducing an elliptical motion of the surgical tip. Compared with a solely longitudinal ultrasonic vibration-assisted (UV-A) electrosurgical device, the EUV-A electrode contacts the tissue intermittently, thus allowing for a cooler cut and preventing tissue accumulation. The experimental results reveal that the EUV-A electrode demonstrates better performance than the UV-A electrode for both anti-adhesion and thermal injury through in vitro experiments in porcine samples. The tissue removal mechanism of EUV-A electrosurgical cutting is modeled to investigate its anti-adhesion effect. In addition, lower adhesion, lower temperature, and faster cutting are demonstrated through in vivo experiments in rabbit samples. Results show that the EUV-A electrode causes lower thermal injury, indicative of faster postoperative healing. Finally, efficacy of the hemostatic effect of the EUV-A electrode is demonstrated in vivo for vessels up to 3.5 mm (equivalent to that of electrocautery). The study reveals that the EUV-A electrosurgical cutting system can achieve safe tissue incision and hemostasis.
Collapse
Affiliation(s)
- Guang Yao
- Guangdong Provincial Key Laboratory of Minimally Invasive Surgical Instruments and Manufacturing Technology, Guangdong University of Technology, Guangzhou 510006, China
| | - Fei Wu
- Guangdong Provincial Key Laboratory of Minimally Invasive Surgical Instruments and Manufacturing Technology, Guangdong University of Technology, Guangzhou 510006, China
| | - Margaret Lucas
- James Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK
| | - Lijuan Zheng
- Guangdong Provincial Key Laboratory of Minimally Invasive Surgical Instruments and Manufacturing Technology, Guangdong University of Technology, Guangzhou 510006, China
| | - Chengyong Wang
- Guangdong Provincial Key Laboratory of Minimally Invasive Surgical Instruments and Manufacturing Technology, Guangdong University of Technology, Guangzhou 510006, China.
| | - Heng Gu
- Guangdong Institute of Medical Instruments, Guangzhou 510500, China
| |
Collapse
|
4
|
Lucas M, Danilov AV, Levitin LV, Jayaraman A, Casey AJ, Faoro L, Tzalenchuk AY, Kubatkin SE, Saunders J, de Graaf SE. Quantum bath suppression in a superconducting circuit by immersion cooling. Nat Commun 2023; 14:3522. [PMID: 37316500 DOI: 10.1038/s41467-023-39249-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Accepted: 06/02/2023] [Indexed: 06/16/2023] Open
Abstract
Quantum circuits interact with the environment via several temperature-dependent degrees of freedom. Multiple experiments to-date have shown that most properties of superconducting devices appear to plateau out at T ≈ 50 mK - far above the refrigerator base temperature. This is for example reflected in the thermal state population of qubits, in excess numbers of quasiparticles, and polarisation of surface spins - factors contributing to reduced coherence. We demonstrate how to remove this thermal constraint by operating a circuit immersed in liquid 3He. This allows to efficiently cool the decohering environment of a superconducting resonator, and we see a continuous change in measured physical quantities down to previously unexplored sub-mK temperatures. The 3He acts as a heat sink which increases the energy relaxation rate of the quantum bath coupled to the circuit a thousand times, yet the suppressed bath does not introduce additional circuit losses or noise. Such quantum bath suppression can reduce decoherence in quantum circuits and opens a route for both thermal and coherence management in quantum processors.
Collapse
Affiliation(s)
- M Lucas
- Physics Department, Royal Holloway University of London, Egham, UK
| | - A V Danilov
- Department of Microtechnology and Nanoscience MC2, Chalmers University of Technology, SE-412 96, Göteborg, Sweden
| | - L V Levitin
- Physics Department, Royal Holloway University of London, Egham, UK
| | - A Jayaraman
- Department of Microtechnology and Nanoscience MC2, Chalmers University of Technology, SE-412 96, Göteborg, Sweden
| | - A J Casey
- Physics Department, Royal Holloway University of London, Egham, UK
| | - L Faoro
- Google Quantum AI, Google Research, Mountain View, CA, USA
| | - A Ya Tzalenchuk
- Physics Department, Royal Holloway University of London, Egham, UK
- National Physical Laboratory, Teddington, TW11 0LW, UK
| | - S E Kubatkin
- Department of Microtechnology and Nanoscience MC2, Chalmers University of Technology, SE-412 96, Göteborg, Sweden
| | - J Saunders
- Physics Department, Royal Holloway University of London, Egham, UK
| | - S E de Graaf
- National Physical Laboratory, Teddington, TW11 0LW, UK.
| |
Collapse
|
5
|
Ingen-Housz-Oro S, Schmidt V, Ameri MM, Abe R, Brassard A, Mostaghimi A, Paller AS, Romano A, Didona B, Kaffenberger BH, Ben Said B, Thong BYH, Ramsay B, Brezinova E, Milpied B, Mortz CG, Chu CY, Sotozono C, Gueudry J, Fortune DG, Dridi SM, Tartar D, Do-Pham G, Gabison E, Phillips EJ, Lewis F, Salavastru C, Horvath B, Dart J, Setterfield J, Newman J, Schulz JT, Delcampe A, Brockow K, Seminario-Vidal L, Jörg L, Watson MP, Gonçalo M, Lucas M, Torres M, Noe MH, Hama N, Shear NH, O’Reilly P, Wolkenstein P, Romanelli P, Dodiuk-Gad RP, Micheletti RG, Tiplica GS, Sheridan R, Rauz S, Ahmad S, Chua SL, Flynn TH, Pichler W, Le ST, Maverakis E, Walsh S, French LE, Brüggen MC. Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus. Orphanet J Rare Dis 2023; 18:33. [PMID: 36814255 PMCID: PMC9945700 DOI: 10.1186/s13023-023-02631-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Accepted: 02/06/2023] [Indexed: 02/24/2023] Open
Abstract
BACKGROUND Long-term sequelae are frequent and often disabling after epidermal necrolysis (Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)). However, consensus on the modalities of management of these sequelae is lacking. OBJECTIVES We conducted an international multicentric DELPHI exercise to establish a multidisciplinary expert consensus to standardize recommendations regarding management of SJS/TEN sequelae. METHODS Participants were sent a survey via the online tool "Survey Monkey" consisting of 54 statements organized into 8 topics: general recommendations, professionals involved, skin, oral mucosa and teeth, eyes, genital area, mental health, and allergy workup. Participants evaluated the level of appropriateness of each statement on a scale of 1 (extremely inappropriate) to 9 (extremely appropriate). Results were analyzed according to the RAND/UCLA Appropriateness Method. RESULTS Fifty-two healthcare professionals participated. After the first round, a consensus was obtained for 100% of 54 initially proposed statements (disagreement index < 1). Among them, 50 statements were agreed upon as 'appropriate'; four statements were considered 'uncertain', and ultimately finally discarded. CONCLUSIONS Our DELPHI-based expert consensus should help guide physicians in conducting a prolonged multidisciplinary follow-up of sequelae in SJS-TEN.
Collapse
Affiliation(s)
- S. Ingen-Housz-Oro
- grid.412116.10000 0004 1799 3934Department of Dermatology, AP-HP, Henri Mondor Hospital, 1 Rue Gustave Eiffel, 94000 Créteil, France ,ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France ,grid.410511.00000 0001 2149 7878EpiDermE, Université Paris Est Créteil, Créteil, France
| | - V. Schmidt
- grid.410567.1University Hospital Basel, Basel, Switzerland ,grid.7400.30000 0004 1937 0650Faculty of Medicine, University of Zurich, Zurich, Switzerland
| | - M. M. Ameri
- grid.7400.30000 0004 1937 0650Faculty of Medicine, University of Zurich, Zurich, Switzerland ,grid.412004.30000 0004 0478 9977Department of Dermatology, University Hospital Zurich, Zurich, Switzerland ,grid.507894.70000 0004 4700 6354Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland
| | - R. Abe
- grid.260975.f0000 0001 0671 5144Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
| | - A. Brassard
- grid.413079.80000 0000 9752 8549Department of Dermatology, UC Davis Medical Center, Sacramento, CA USA
| | - A. Mostaghimi
- grid.62560.370000 0004 0378 8294Department of Dermatology, Brigham and Women’s Hospital, Boston, MA USA
| | - A. S. Paller
- grid.16753.360000 0001 2299 3507Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL USA
| | - A. Romano
- grid.419843.30000 0001 1250 7659Oasi Research Institute-IRCCS, Troina, Italy
| | - B. Didona
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.419457.a0000 0004 1758 0179Rare Disease Unit, I Dermatology Division, Istituto Dermopatico Dell’Immacolata, IRCCS, Rome, Italy
| | - B. H. Kaffenberger
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.412332.50000 0001 1545 0811The Ohio State University Wexner Medical Center Division of Dermatology, Upper Arlington, OH USA
| | - B. Ben Said
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France ,Department of Dermatology, CHU Edouard Herriot, Lyon, France
| | - B. Y. H. Thong
- grid.240988.f0000 0001 0298 8161Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore
| | - B. Ramsay
- grid.415522.50000 0004 0617 6840Department of Dermatology, University Hospital Limerick, Limerick, Ireland
| | - E. Brezinova
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.10267.320000 0001 2194 0956First Department of Dermatovenereology, Masaryk University Faculty of Medicine, St. Ann’s Faculty Hospital in Brno, Brno, Czech Republic
| | - B. Milpied
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France ,grid.412041.20000 0001 2106 639XDepartment of Adult and Pediatric Dermatology, Bordeaux University Hospitals, Bordeaux, France
| | - C. G. Mortz
- grid.7143.10000 0004 0512 5013Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark
| | - C. Y. Chu
- grid.19188.390000 0004 0546 0241Department of Dermatology, National Taiwan University Hospital, National Taiwan University College of Medicine, No. 7, Chung-Shan South Road, Taipei, 10002 Taiwan
| | - C. Sotozono
- grid.272458.e0000 0001 0667 4960Department of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Hirokoji-Agaru, Kawaramach-Dori, Kamigyo-Ku, Kyoto, 602-0841 Japan
| | - J. Gueudry
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France ,grid.417615.0Department of Ophthalmology, CHU Charles-Nicolle, Rouen, France
| | - D. G. Fortune
- grid.10049.3c0000 0004 1936 9692Department of Psychology, University of Limerick, Limerick, Ireland
| | - S. M. Dridi
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France ,grid.416670.2MICORALIS Laboratory, Department of Periodontology, Faculty of Dentistry, Côte d’Azur University, Saint Roch Hospital, Nice, France
| | - D. Tartar
- grid.27860.3b0000 0004 1936 9684Department of Dermatology, University of California Davis, Sacramento, CA USA
| | - G. Do-Pham
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France ,grid.414145.10000 0004 1765 2136Department of Internal Medicine, Centre Hospitalier Intercommunal de Créteil, Créteil, France
| | - E. Gabison
- grid.417888.a0000 0001 2177 525XFondation Ophtalmologique Adolphe de Rothschild, Paris, France
| | - E. J. Phillips
- grid.1025.60000 0004 0436 6763Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA Australia ,grid.412807.80000 0004 1936 9916Department of Medicine, Vanderbilt University Medical Center, Nashville, TN USA
| | - F. Lewis
- grid.425213.3St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospital, London, UK
| | - C. Salavastru
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,Department of Paediatric Dermatology, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - B. Horvath
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.4830.f0000 0004 0407 1981Department of Dermatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
| | - J. Dart
- grid.83440.3b0000000121901201Moorfields Eye Hospital NHS Foundation Trust, The UCL Institute of Ophthalmology, London, UK
| | - J. Setterfield
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.420545.20000 0004 0489 3985Department of Oral Medicine, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
| | - J. Newman
- grid.429705.d0000 0004 0489 4320Department of Dermatology, King’s College Hospital NHS Foundation Trust, London, UK
| | - J. T. Schulz
- grid.32224.350000 0004 0386 9924Division of Burns, Massachusetts General Hospital, Boston, 02114 USA
| | - A. Delcampe
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France ,grid.417615.0Department of Ophthalmology, CHU Charles-Nicolle, Rouen, France ,grid.417888.a0000 0001 2177 525XFondation Ophtalmologique Adolphe de Rothschild, Paris, France ,grid.411119.d0000 0000 8588 831XDepartment of Ophthalmology, CHU Bichat-Claude Bernard, Paris, France
| | - K. Brockow
- grid.6936.a0000000123222966Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany
| | - L. Seminario-Vidal
- grid.170693.a0000 0001 2353 285XDepartment of Dermatology and Cutaneous Surgery, University of South Florida, Tampa, FL USA
| | - L. Jörg
- grid.412004.30000 0004 0478 9977Department of Dermatology, University Hospital Zurich, Zurich, Switzerland ,grid.5734.50000 0001 0726 5157Division of Allergology and Clinical Immunology, Department of Pneumology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - M. P. Watson
- grid.439257.e0000 0000 8726 5837Cornea and External Eye Disease Service, Moorfields Eye Hospital, London, UK
| | - M. Gonçalo
- grid.28911.330000000106861985Department of Dermatology, Coimbra University Hospital Center, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
| | - M. Lucas
- grid.1012.20000 0004 1936 7910Medical School, University of Western Australia, Perth, WA 6009 Australia ,grid.3521.50000 0004 0437 5942Department of Immunology, Sir Charles Gairdner Hospital, Pathwest Laboratory Medicine, Perth, WA 6009 Australia
| | - M. Torres
- grid.452525.1Allergy Unit, IBIMA-Regional University Hospital of Malaga-UMA, Málaga, Spain
| | - M. H. Noe
- grid.62560.370000 0004 0378 8294Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
| | - N. Hama
- grid.260975.f0000 0001 0671 5144Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
| | - N. H. Shear
- grid.17063.330000 0001 2157 2938Department of Dermatology, University of Toronto, Toronto, ON Canada ,grid.413104.30000 0000 9743 1587Sunnybrook Health Sciences Centre, Toronto, ON Canada
| | - P. O’Reilly
- grid.10049.3c0000 0004 1936 9692Department of Nursing and Midwifery, University of Limerick, Limerick, Ireland
| | - P. Wolkenstein
- grid.412116.10000 0004 1799 3934Department of Dermatology, AP-HP, Henri Mondor Hospital, 1 Rue Gustave Eiffel, 94000 Créteil, France ,ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France
| | - P. Romanelli
- grid.26790.3a0000 0004 1936 8606Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, FL USA
| | - R. P. Dodiuk-Gad
- grid.6451.60000000121102151Dermatology Department, Emek Medical Center, Bruce Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel ,grid.17063.330000 0001 2157 2938Department of Medicine, University of Toronto, Toronto, Canada
| | - R. G. Micheletti
- grid.25879.310000 0004 1936 8972Department of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA
| | - G. S. Tiplica
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,2Nd Department of Dermatology, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - R. Sheridan
- grid.415829.30000 0004 0449 5362Burn Service, Boston Shriners Hospital for Children, Boston, MA USA ,grid.32224.350000 0004 0386 9924Division of Burns, Massachusetts General Hospital, Boston, MA USA ,grid.38142.3c000000041936754XDepartment of Surgery, Harvard Medical School, Boston, MA USA
| | - S. Rauz
- grid.6572.60000 0004 1936 7486Academic Unit of Ophthalmology, Birmingham and Midland Eye Centre, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - S. Ahmad
- grid.83440.3b0000000121901201Moorfields Eye Hospital NHS Foundation Trust, The UCL Institute of Ophthalmology, London, UK
| | - S. L. Chua
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.412563.70000 0004 0376 6589Department of Dermatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - T. H. Flynn
- grid.460892.10000 0004 0389 5639Ophthalmology, Bon Secours Hospital, Cork, Ireland
| | - W. Pichler
- grid.482939.dADR-AC GmbH, Bern, Switzerland
| | - S. T. Le
- grid.413079.80000 0000 9752 8549Department of Dermatology, UC Davis Medical Center, Sacramento, CA USA
| | - E. Maverakis
- grid.413079.80000 0000 9752 8549Department of Dermatology, UC Davis Medical Center, Sacramento, CA USA
| | - S. Walsh
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.429705.d0000 0004 0489 4320Department of Dermatology, King’s College Hospital NHS Foundation Trust, London, UK
| | - L. E. French
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.411095.80000 0004 0477 2585Department of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany ,grid.26790.3a0000 0004 1936 8606Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL USA
| | - M. C. Brüggen
- ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris, France ,grid.7400.30000 0004 1937 0650Faculty of Medicine, University of Zurich, Zurich, Switzerland ,grid.412004.30000 0004 0478 9977Department of Dermatology, University Hospital Zurich, Zurich, Switzerland ,grid.507894.70000 0004 4700 6354Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland
| |
Collapse
|
6
|
Lucas M, Merchant M, O’Connor M, Smith S, Trombino A, Waters N, Eathiraj S, Buck E. BDTX-1535, a fourth generation EGFR inhibitor, targeting intrinsic and acquired resistance mutations in NSCLC. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00862-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
7
|
Gupta D, Savva J, Li X, Chandler JH, Shelton RM, Scheven BA, Mulvana H, Valdastri P, Lucas M, Walmsley AD. Traditional Multiwell Plates and Petri Dishes Limit the Evaluation of the Effects of Ultrasound on Cells In Vitro. Ultrasound Med Biol 2022; 48:1745-1761. [PMID: 35760602 DOI: 10.1016/j.ultrasmedbio.2022.05.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Revised: 04/29/2022] [Accepted: 05/02/2022] [Indexed: 06/15/2023]
Abstract
Ultrasound accelerates healing in fractured bone; however, the mechanisms responsible are poorly understood. Experimental setups and ultrasound exposures vary or are not adequately characterized across studies, resulting in inter-study variation and difficulty in concluding biological effects. This study investigated experimental variability introduced through the cell culture platform used. Continuous wave ultrasound (45 kHz; 10, 25 or 75 mW/cm2, 5 min/d) was applied, using a Duoson device, to Saos-2 cells seeded in multiwell plates or Petri dishes. Pressure field and vibration quantification and finite-element modelling suggested formation of complex interference patterns, resulting in localized displacement and velocity gradients, more pronounced in multiwell plates. Cell experiments revealed lower metabolic activities in both culture platforms at higher ultrasound intensities and absence of mineralization in certain regions of multiwell plates but not in Petri dishes. Thus, the same transducer produced variable results in different cell culture platforms. Analysis on Petri dishes further revealed that higher intensities reduced vinculin expression and distorted cell morphology, while causing mitochondrial and endoplasmic reticulum damage and accumulation of cells in sub-G1 phase, leading to cell death. More defined experimental setups and reproducible ultrasound exposure systems are required to study the real effect of ultrasound on cells for development of effective ultrasound-based therapies not just limited to bone repair and regeneration.
Collapse
Affiliation(s)
- Dhanak Gupta
- School of Dentistry, University of Birmingham, Birmingham, UK.
| | - Jill Savva
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow, UK
| | - Xuan Li
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow, UK
| | - James H Chandler
- Science and Technology of Robotics in Medicine (STORM) Laboratory UK, School of Electronic and Electrical Engineering, University of Leeds, Leeds, UK
| | | | - Ben A Scheven
- School of Dentistry, University of Birmingham, Birmingham, UK
| | - Helen Mulvana
- Department of Biomedical Engineering, University of Strathclyde, Glasgow, UK
| | - Pietro Valdastri
- Science and Technology of Robotics in Medicine (STORM) Laboratory UK, School of Electronic and Electrical Engineering, University of Leeds, Leeds, UK
| | - Margaret Lucas
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow, UK
| | | |
Collapse
|
8
|
Lucas M, Freitas M, Zanchetta M, Silva V, Silva A, Fernandes E, Ribeiro D. P12-41 Cytotoxicity and anti-inflammatory potential of 2-styrylchromones. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
9
|
Cleary R, Wallace R, Simpson H, Kontorinis G, Lucas M. A longitudinal-torsional mode ultrasonic needle for deep penetration into bone. Ultrasonics 2022; 124:106756. [PMID: 35597040 DOI: 10.1016/j.ultras.2022.106756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Revised: 04/06/2022] [Accepted: 05/01/2022] [Indexed: 06/15/2023]
Abstract
This work presents a longitudinal-torsional (L-T) composite mode ultrasonic needle device for deep bone penetration. The L-T needle is a geometrically modified version of an L-mode needle whose efficacy as a prototype ultrasonic bone biopsy device has been previously demonstrated by the authors. Finite element analysis (FEA) aided in the design of the L-T needle, with the aim of maximising the achievable torsional displacement while matching the longitudinal displacement achieved by the L-mode needle. Experimental modal analysis (EMA) of the fabricated ultrasonic device was used to identify the modal parameters and validate the FEA model. Harmonic analysis then provided an insight into how the inherent nonlinearities of the high-power transducer are affected by incorporating the geometrical features that degenerate the L mode into an L-T mode. High power characterisation shows that the longitudinal displacement amplitude of the L-T mode needle is larger than that of the L-mode needle. Comparative penetration tests in fresh Wistar rat skull were evaluated by investigating cell death and cell survival. The region of statistically significant cell death was small for both devices, with the combined axial and shear motion of the L-T device causing increased osteocyte necrosis within this region. Nevertheless, the results suggest a promising environment for post-operative healing. It is shown how this technology offers a potential technique for a surgical approach to the petrous apex, an application that requires a deep penetration into bone.
Collapse
Affiliation(s)
- Rebecca Cleary
- James Watt School of Engineering, University of Glasgow, Glasgow, UK
| | - Robert Wallace
- Department of Orthopaedics and Trauma, School of Clinical Sciences, University of Edinburgh, Edinburgh, UK
| | - Hamish Simpson
- Department of Orthopaedics and Trauma, School of Clinical Sciences, University of Edinburgh, Edinburgh, UK
| | | | - Margaret Lucas
- James Watt School of Engineering, University of Glasgow, Glasgow, UK.
| |
Collapse
|
10
|
Rogers KA, Huang Y, Abruzzo L, Bhat SA, Doong TJ, Kittai A, Lozanski A, Lozanski G, Lucas M, Maddocks KJ, Mao C, Nussbaum M, Sass EJ, Suresh S, Byrd JC, Woyach JA. Four-year follow-up from a phase 2 study of obinutuzumab, ibrutinib, and venetoclax in CLL. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.7540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7540 Background: Targeted agent combinations for chronic lymphocytic leukemia (CLL) have resulted in safe regimens with improved progression-free survival (PFS) compared to chemoimmunotherapy. The optimal regimen and long-term outcomes remain unknown. We conducted a phase 2 study of obinutuzumab (OBIN), ibrutinib (IBR), and venetoclax (VEN) in relapsed/refractory (RR) and treatment-naïve (TN) CLL patients (pts) and report extended follow up on two previously reported cohorts (RR, TN 1) and a new cohort of identically treated TN pts (TN 2). Methods: Pts with TN or RR (≥1 prior treatment) CLL requiring treatment were eligible. Treatment was given for 14 28-day cycles (C). OBIN was started C1, IBR C2, and VEN C3 with standard dose escalation. Response was assessed 2 months (mos) after C14 (EOT) by iwCLL 2008 criteria. Minimal residual disease (MRD) was measured by 10-color flow cytometry with a cutoff of < 1x10-4. The primary endpoint was complete remission (CR) with undetectable MRD (uMRD) in blood and bone marrow at EOT. A sample size of 25 pts per cohort achieves 90% power to test the null hypothesis of 10% against 30% with 1-sided α of 10%. The Kaplan-Meier method was used to estimate PFS and overall survival (OS). Results: 75 pts were treated in 3 cohorts (Table). Data are as of 1/3/2022. In the TN 2 cohort, the overall response rate (ORR) at EOT was 96% (95% CI: 80-100) and CR with uMRD was 20% (95% CI: 7-41). The ORR for TN 1 and TN 2 combined was 90% (95% CI: 78-97) and CR with uMRD was 24% (95% CI: 13-38). Median follow up was 56 (0-65), 57 (7-63), and 30 (24-35) mos, respectively, for RR, TN 1, and TN 2. There were 3 deaths (RR = 1, TN 1 = 1, TN 2 = 1) and 6 disease progressions (RR = 4, TN 1 = 2, TN 2 = 0). Estimated 48-month PFS for TN 1 and RR cohorts were both 96% (95% CI: 72-99) and OS was 85% (95% CI: 60-95) and 100%, respectively. The estimated 24-month PFS and OS for TN 2 were both 96% (95% CI: 75-99). The most frequent adverse events were neutropenia (95%, 73% grade ≥3), leukopenia (95%, 45% grade ≥3), lymphopenia (93%, 40% grade ≥3), and thrombocytopenia (91%, 28% grade ≥3). The only grade ≥3 non-hematologic toxicity occurring at ≥20% was hypertension (85%, 39% grade ≥3). Atrial fibrillation occurred in 11% of pts. Conclusions: At extended follow-up, remissions remain durable after fixed duration OBIN, IBR, and VEN. The efficacy and acceptable safety justify further study and are being compared to IBR and OBIN in 2 phase 3 US cooperative group trials. Clinical trial information: NCT02427451. [Table: see text]
Collapse
Affiliation(s)
| | - Ying Huang
- Division of Hematology, The Ohio State University, Columbus, OH
| | - Lynne Abruzzo
- Department of Pathology, The Ohio State University, Columbus, OH
| | - Seema Ali Bhat
- Division of Hematology, The Ohio State University, Columbus, OH
| | - Tzyy-Jye Doong
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Adam Kittai
- Division of Hematology, The Ohio State University, Columbus, OH
| | - Arletta Lozanski
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Gerard Lozanski
- Department of Pathology, The Ohio State University, Columbus, OH
| | - Margaret Lucas
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | | | - Charelen Mao
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Megan Nussbaum
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Ellen J Sass
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Swetha Suresh
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - John C. Byrd
- Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
| | | |
Collapse
|
11
|
Hurley C, Lacroix L, Lucas M, Buckley R, Blümel A, Sheehan K, Toomey S, Hennessy B, Crown J, Sautes-Fridman C, O'Connor D. 41P The impact of tumour-infiltrating lymphocyte subpopulations on pathological complete response in HER2+ breast cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.03.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
12
|
Newman J, Lucas M, Stefanovska A. Stabilization of cyclic processes by slowly varying forcing. Chaos 2021; 31:123129. [PMID: 34972346 DOI: 10.1063/5.0066641] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Accepted: 10/22/2021] [Indexed: 06/14/2023]
Abstract
We introduce a new mathematical framework for the qualitative analysis of dynamical stability, designed particularly for finite-time processes subject to slow-timescale external influences. In particular, our approach is to treat finite-time dynamical systems in terms of a slow-fast formalism in which the slow time only exists in a bounded interval, and consider stability in the singular limit. Applying this to one-dimensional phase dynamics, we provide stability definitions somewhat analogous to the classical infinite-time definitions associated with Aleksandr Lyapunov. With this, we mathematically formalize and generalize a phase-stabilization phenomenon previously described in the physics literature for which the classical stability definitions are inapplicable and instead our new framework is required.
Collapse
Affiliation(s)
- J Newman
- Centre for Systems, Dynamics and Control, Department of Mathematics, University of Exeter, Exeter EX4 4QF, United Kingdom
| | - M Lucas
- Dipartimento di Fisica e Astronomia, Università di Firenze, INFN and CSDC, Via Sansone 1, 50019 Sesto Fiorentino, Firenze, Italy
| | - A Stefanovska
- Department of Physics, Lancaster University, Lancaster LA1 4YB, United Kingdom
| |
Collapse
|
13
|
Cleary R, Li X, Lucas M. Incorporating direct metal laser sintered complex shaped Ti-6Al-4V components in ultrasonic surgical devices. J Acoust Soc Am 2021; 150:2163. [PMID: 34598605 DOI: 10.1121/10.0006379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Accepted: 08/26/2021] [Indexed: 06/13/2023]
Abstract
Additive manufacturing (AM) offers opportunities to design more complex shapes of the Ti-6Al-4V parts commonly used in high-power ultrasonic surgical devices. Moreover, AM metal printing will be essential to the realization of miniature ultrasonic devices incorporating internal structures for minimally invasive surgical procedures. However, it is necessary first to verify the ultrasonic vibrational behavior of devices with three-dimensional (3D) printed metal parts. Therefore, two different prototype devices are fabricated, with CNC machined mill annealed and 3D printed Ti-6Al-4V parts. Both devices, an ultrasonic bone needle and a miniature ultrasonic scalpel, incorporate complex geometries but can be manufactured using subtractive processes so that the comparative effects of 3D printing on the vibrational performance of the devices can be elucidated. The metal microstructure is investigated through measurements of longitudinal and shear acoustic velocities and scanning electron microscopy. Comparisons of electrical impedance, frequency and modal responses, and the vibrational response at increasing levels of excitation enable evaluation of the efficacy of incorporating 3D printed Ti-6Al-4V parts. Results show that whereas the bone needle exhibited comparable vibrational responses for the measurement techniques used, the 3D printed bone cutting device exhibited a more dense modal response and developed cracks at high excitation levels.
Collapse
Affiliation(s)
- Rebecca Cleary
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom
| | - Xuan Li
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom
| | - Margaret Lucas
- Centre for Medical & Industrial Ultrasonics, James Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom
| |
Collapse
|
14
|
Li X, Stritch T, Manley K, Lucas M. Limits and Opportunities for Miniaturizing Ultrasonic Surgical Devices Based on a Langevin Transducer. IEEE Trans Ultrason Ferroelectr Freq Control 2021; 68:2543-2553. [PMID: 33690118 DOI: 10.1109/tuffc.2021.3065207] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Minimally invasive surgery offers opportunities for reduced morbidities, faster postoperative recovery, and reduced costs, and is a major focus of surgical device innovation. For ultrasonic surgical devices, which offer benefits of high precision, low force, and tissue selectivity in surgical procedures, there exist laparoscopic ultrasonic shears for minimally invasive surgeries that combine tissue cutting with vessel hemostasis and sealing functions. Another approach to laparoscopy that could enable new procedures, and increase the sites of surgeries that could be reached by an ultrasonic device, involves integrating a miniature ultrasonic tool with a flexible surgical robot. However, miniaturization presents challenges in delivering the ultrasonic vibrational energy required to cut hard and soft tissues, partly due to the concomitant small volume of piezoelectric material. This article aims to provide insights into the trade-offs between transducer size, volume of piezoceramic material, resonance frequency, and the achievable displacement amplitude of devices that, consistent with current ultrasonic surgical tools, are based on a bolted Langevin transducer (BLT) and tip. Different configurations of BLTs are studied, including a cascaded version, simple bar versions, and BLTs with different front mass geometries. Results show that a BLT with a larger number of piezoceramic rings exhibits a higher coupling coefficient [Formula: see text] but with the compromise of a lower mechanical Q and stronger nonlinear response at increasing excitation levels. Displacement amplitude is reduced considerably when a BLT is excited at a higher harmonic, where the PZT rings are maintained at a nodal plane, and the resonance frequency shift at increasing excitation levels increases significantly. The electromechanical and dynamic characteristics of a cascaded transducer excited in its third longitudinal mode (L3) are almost equivalent to a much shorter version of a BLT driven at the same frequency but in its first longitudinal mode (L1), showing that a cascaded BLT can be a realistic proxy for studying the dynamics of small BLT devices. A new figure of merit is proposed that is the product of Q , [Formula: see text], and gain, which [Formula: see text] accounts for the gain of cylindrical BLTs which is shown not to be unity. It also proves effective as it incorporates the key factors affecting the achievable displacement amplitude of a BLT, including for BLTs with gain profiles in the front mass. The order of highest to lowest amplitude of a series of six gain-profile BLTs matches the order estimated by the figure of merit. It is shown that a BLT with a stepped profile front mass can achieve displacement that has the potential to cut hard or soft tissue and exhibits the smallest shifts in resonance frequency at increasing excitation levels.
Collapse
|
15
|
Dardenne E, Padilla F, Rasmussen S, Yang S, Mentes A, Ogawa L, Fiorenza R, Trombino A, Smith S, Romashko D, Ishiyama N, Chevtsova M, Thakur S, Rosfjord E, Buck E, Roberts C, Lucas M, Lin TA. 35MO Discovery and characterization of selective, FGFR1-sparing, inhibitors of FGFR2/3 oncogenic mutations for the treatment of cancers. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.01.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
16
|
Han YC, Ng P, Schulz R, Yang S, Lelo A, Ogawa L, O'Connor M, Ishiyama N, Jewett I, Romashko D, Salomatov A, Thakur S, Smith S, Buck E, Roberts C, Lucas M, Lin TA. 43P Pre-clinical evaluation of potent and orally bioavailable next-generation inhibitors targeting the family of mutants that drive oncogenic BRAF dimer formation. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.01.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
17
|
Biswas S, Dinh D, Lucas M, Duffy S, Brennan A, Liew D, Cox N, Nadurata V, Reid C, Lefkovits J, Stub D. Incidence, causes and predictors of unplanned hospital readmission after percutaneous coronary intervention. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Unplanned hospital readmissions post-percutaneous coronary intervention (PCI) result in a significant burden to the healthcare system and adverse patient outcomes. Understanding factors associated with 30-day readmission rates may help to reduce this burden. Data linkage of clinical quality registry data with routinely collected administrative datasets may assist in overcoming resource constraints that limit collection of follow-up data but is currently under-utilised worldwide.
Objective
To determine the incidence of, and factors associated with unplanned hospital readmissions in the first 30 days following PCI.
Methods
We prospectively collected data on 28,488 patients undergoing PCI between January 2013 and December 2018, who were enrolled in a multi-centre PCI registry. Data linkage to government administrative datasets was used to determine whether patients had an unplanned readmission within 30 days of PCI, the number of admissions prior to PCI and primary reason for readmission (as recorded by the International Classification of Diseases, 10th revision, Australian modification (ICD-10-AM) diagnosis codes). Patients were then divided into 3 groups: those who had 1 or more unplanned readmissions for primarily cardiac issues, those who those who had 1 or more unplanned readmissions for primarily non-cardiac issues, and those who were not readmitted, and compared for baseline, procedural and in-hospital care characteristics.
Results
In total, 3,059 patients (10.7%) had an unplanned hospital readmission within 30 days of PCI, of which, 1,848 patients (60.4%) were readmitted for primarily cardiac diagnoses. Independent predictors of both 30-day cardiac and non-cardiac readmissions were female sex, having >1 admission in the 12 months prior to PCI, acute coronary syndrome presentation, having any in-hospital complication and being discharged on an oral anticoagulant (all p<0.05). A stepwise increase in readmission risk was observed with increasing number of admissions from 1 to >4 admissions in the 12 months prior to PCI. Presentation with cardiogenic shock (p=0.04), having an unsuccessful PCI (p=0.02) and left ventricular systolic dysfunction (p=0.02) were independent predictors of cardiac readmissions but not non-cardiac readmissions. Conversely, age >60 years (p<0.001) and history of diabetes mellitus (p=0.02) were found to be independent predictors of non-cardiac readmissions only.
Conclusion
Thirty-day unplanned hospital readmissions after PCI pose a significant burden to the health system. Most readmissions are primarily due to cardiac diagnoses. The most important predictive factor for both cardiac and non-cardiac readmissions appears to be the number of hospital admissions in the 12 months prior to PCI. This is valuable information for health administrators as treatment and discharge policies, and outpatient follow-up timetables may need to be tailored to patients at high risk for readmission following PCI.
Causes of readmission post-PCI
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- S Biswas
- Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
| | - D Dinh
- Monash University, Melbourne, Australia
| | - M Lucas
- Monash University, Melbourne, Australia
| | - S.J Duffy
- The Alfred Hospital, Cardiology, Melbourne, Australia
| | - A Brennan
- Monash University, Melbourne, Australia
| | - D Liew
- Monash University, Melbourne, Australia
| | - N Cox
- Western Health, Cardiology, Melbourne, Australia
| | - V Nadurata
- Bendigo health, Cardiology, Bendigo, Australia
| | - C.M Reid
- Monash University, Melbourne, Australia
| | | | - D Stub
- The Alfred Hospital, Cardiology, Melbourne, Australia
| |
Collapse
|
18
|
Rogers KA, Huang Y, Ruppert AS, Abruzzo LV, Andersen BL, Awan FT, Bhat SA, Dean A, Lucas M, Banks C, Grantier C, Heerema NA, Lozanski G, Maddocks KJ, Valentine TR, Weiss DM, Jones JA, Woyach JA, Byrd JC. Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia. J Clin Oncol 2020; 38:3626-3637. [PMID: 32795224 DOI: 10.1200/jco.20.00491] [Citation(s) in RCA: 68] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
PURPOSE The development of highly effective targeted agents for chronic lymphocytic leukemia offers the potential for fixed-duration combinations that achieve deep remissions without cytotoxic chemotherapy. PATIENTS AND METHODS This phase II study tested a combination regimen of obinutuzumab, ibrutinib, and venetoclax for a total of 14 cycles in both patients with treatment-naïve (n = 25) and relapsed or refractory (n = 25) chronic lymphocytic leukemia to determine the response to therapy and safety. RESULTS The primary end point was the rate of complete remission with undetectable minimal residual disease by flow cytometry in both the blood and bone marrow 2 months after completion of treatment, which was 28% in both groups. The overall response rate at that time was 84% in treatment-naïve patients and 88% in relapsed or refractory patients. At that time, 67% of treatment-naïve patients and 50% of relapsed or refractory patients had undetectable minimal residual disease in both the blood and marrow. At a median follow-up of 24.2 months in treatment-naïve patients and 21.5 months in relapsed or refractory patients, the median progression-free and overall survival times were not yet reached, with only 1 patient experiencing progression and 1 death. Neutropenia and thrombocytopenia were the most frequent adverse events, followed by hypertension. Grade 3 or 4 neutropenia was experienced by 66% of patients, with more events in the relapsed or refractory cohort. There was only 1 episode of neutropenic fever. A favorable impact on both perceived and objective cognitive performance during treatment was observed. CONCLUSION The combination regimen of obinutuzumab, ibrutinib, and venetoclax offers time-limited treatment that results in deep remissions and is now being studied in phase III cooperative group trials.
Collapse
Affiliation(s)
- Kerry A Rogers
- Division of Hematology, The Ohio State University, Columbus, OH.,The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Ying Huang
- Division of Hematology, The Ohio State University, Columbus, OH
| | - Amy S Ruppert
- Division of Hematology, The Ohio State University, Columbus, OH
| | - Lynne V Abruzzo
- Department of Pathology, The Ohio State University, Columbus, OH
| | | | - Farrukh T Awan
- Division of Hematology, The Ohio State University, Columbus, OH
| | - Seema A Bhat
- Division of Hematology, The Ohio State University, Columbus, OH
| | - Allison Dean
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Margaret Lucas
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Christin Banks
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Cara Grantier
- The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - Nyla A Heerema
- Department of Pathology, The Ohio State University, Columbus, OH
| | - Gerard Lozanski
- Department of Pathology, The Ohio State University, Columbus, OH
| | - Kami J Maddocks
- Division of Hematology, The Ohio State University, Columbus, OH
| | | | - David M Weiss
- Department of Psychology, The Ohio State University, Columbus, OH
| | - Jeffrey A Jones
- Division of Hematology, The Ohio State University, Columbus, OH
| | - Jennifer A Woyach
- Division of Hematology, The Ohio State University, Columbus, OH.,The Ohio State University Comprehensive Cancer Center, Columbus, OH
| | - John C Byrd
- Division of Hematology, The Ohio State University, Columbus, OH.,The Ohio State University Comprehensive Cancer Center, Columbus, OH
| |
Collapse
|
19
|
Korbl JD, Brusch A, Lucas M, von Nida J, Wood BA, Leecy TN, Harvey NT. A case of severe cutaneous and mucosal erosions. Clin Exp Dermatol 2020; 45:780-782. [PMID: 32410330 DOI: 10.1111/ced.14233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/24/2020] [Indexed: 11/26/2022]
Affiliation(s)
- J D Korbl
- Department of Dermatology, Sir Charles Gairdner Hospital, Perth, Australia
| | - A Brusch
- Department of Immunology, PathWest Laboratory Medicine, Perth, Australia
| | - M Lucas
- Department of Immunology, PathWest Laboratory Medicine, Perth, Australia
| | - J von Nida
- Department of Dermatology, Sir Charles Gairdner Hospital, Perth, Australia
| | - B A Wood
- Department of Anatomical Pathology, PathWest Laboratory Medicine, Perth, Australia.,Division of Pathology and Laboratory Medicine, Medical School, University of Western Australia, Perth, Australia
| | - T N Leecy
- Department of Anatomical Pathology, PathWest Laboratory Medicine, Perth, Australia.,Division of Pathology and Laboratory Medicine, Medical School, University of Western Australia, Perth, Australia
| | - N T Harvey
- Department of Anatomical Pathology, PathWest Laboratory Medicine, Perth, Australia.,Division of Pathology and Laboratory Medicine, Medical School, University of Western Australia, Perth, Australia
| |
Collapse
|
20
|
Alsendi M, Lucas M, Darwish W, Higgins M, Kelly C. 94P Integration of clinicopathological and genomic data and adjuvant treatment decisions in premenopausal women with recurrence scores between 16 and 25. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.03.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
21
|
Cordier S, Anassour-Laouan-Sidi E, Lemire M, Costet N, Lucas M, Ayotte P. Association between exposure to persistent organic pollutants and mercury, and glucose metabolism in two Canadian Indigenous populations. Environ Res 2020; 184:109345. [PMID: 32172074 DOI: 10.1016/j.envres.2020.109345] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Revised: 02/29/2020] [Accepted: 03/02/2020] [Indexed: 06/10/2023]
Abstract
BACKGROUND The body burden of metals and persistent organic pollutants (POPs) is particularly high in populations that rely on fish and other marine species for sustenance. This exposure has been associated with an increased risk of type 2 diabetes, but results remain contrasted. OBJECTIVE We studied this association in two Indigenous populations of northern Québec (Canada) with markedly different prevalences of diabetes and levels of exposure to POPs and mercury. METHODS As part of health surveys conducted in 2004-2009, diabetes prevalence and glucose metabolism (glucose, insulin, HOMA-IR, HOMA-B) in non-diabetic fasting adults were assessed using similar protocols in two populations: Inuit from Nunavik (n = 877) and Cree from Eeyou Istchee territory (n = 780). Blood mercury, plasma polychlorinated biphenyls (PCBs), organochlorine (OC) pesticides/metabolites and polybrominated diphenylethers (PBDEs) levels were measured in samples collected at the time of examination. Logistic and linear regressions and restricted cubic splines analyses were conducted adjusting for sex, age, waist circumference, smoking and omega-3 fatty acid content in plasma phospholipids. RESULTS Diabetes prevalence was higher in Cree (20%) than in Inuit (7%), whereas environmental exposure was 2 to 3-fold greater in Inuit than in Cree participants. In the range of exposure common to the two populations, we observed similar linear increases in the risk of diabetes with increasing contaminant exposure. Among Cree participants, fasting glucose was positively associated with plasma PBDE level, and HOMA-B negatively associated with concentrations of ∑PCBs, dichlorodiphenyldichloroethylene, PBDEs and ∑OC pesticides. Among Inuit participants, a trend towards reduced insulin secretion was observed in association with most contaminants, but the relation was nonlinear (greater reduction at intermediate levels of exposure). A significant increase in fasting glucose levels was observed at elevated blood mercury levels (>16 μg/L). CONCLUSION The observed association between POPs exposure and diabetes risk in the two populations studied should be confirmed using prospective design. Our results suggest the need for additional research on the physiopathological process through which POPs exposure may induce type 2 diabetes in these Indigenous populations.
Collapse
Affiliation(s)
- S Cordier
- Centre de Recherche du CHU de Québec - Université Laval, Québec, Canada; Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé. environnement et travail) - UMR_S1085, F-35000, Rennes, France.
| | | | - M Lemire
- Centre de Recherche du CHU de Québec - Université Laval, Québec, Canada; Département de médecine sociale et préventive, Université Laval, Québec, Canada
| | - N Costet
- Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé. environnement et travail) - UMR_S1085, F-35000, Rennes, France
| | - M Lucas
- Centre de Recherche du CHU de Québec - Université Laval, Québec, Canada; Département de médecine sociale et préventive, Université Laval, Québec, Canada
| | - P Ayotte
- Centre de Recherche du CHU de Québec - Université Laval, Québec, Canada; Département de médecine sociale et préventive, Université Laval, Québec, Canada; Centre de toxicologie du Québec, Institut national de santé publique du Québec, Québec, Canada
| |
Collapse
|
22
|
Niklowitz PG, Hirschberger M, Lucas M, Cermak P, Schneidewind A, Faulhaber E, Mignot JM, Duncan WJ, Neubauer A, Pfleiderer C, Grosche FM. Ultrasmall Moment Incommensurate Spin Density Wave Order Masking a Ferromagnetic Quantum Critical Point in NbFe_{2}. Phys Rev Lett 2019; 123:247203. [PMID: 31922868 DOI: 10.1103/physrevlett.123.247203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/29/2019] [Indexed: 06/10/2023]
Abstract
In the metallic magnet Nb_{1-y}Fe_{2+y}, the low temperature threshold of ferromagnetism can be investigated by varying the Fe excess y within a narrow homogeneity range. We use elastic neutron scattering to track the evolution of magnetic order from Fe-rich, ferromagnetic Nb_{0.981}Fe_{2.019} to approximately stoichiometric NbFe_{2}, in which we can, for the first time, characterize a long-wavelength spin density wave state burying a ferromagnetic quantum critical point. The associated ordering wave vector q_{SDW}=(0,0,l_{SDW}) is found to depend significantly on y and T, staying finite but decreasing as the ferromagnetic state is approached. The phase diagram follows a two-order-parameter Landau theory, for which all of the coefficients can now be determined. Our findings suggest that the emergence of spin density wave order cannot be attributed to band structure effects alone. They indicate a common microscopic origin of both types of magnetic order and provide strong constraints on related theoretical scenarios based on, e.g., quantum order by disorder.
Collapse
Affiliation(s)
- P G Niklowitz
- Department of Physics, Royal Holloway, University of London, Egham TW20 0EX, United Kingdom
| | - M Hirschberger
- Department of Physics, Princeton University, Princeton, New Jersey 08544, USA
| | - M Lucas
- Department of Physics, Royal Holloway, University of London, Egham TW20 0EX, United Kingdom
| | - P Cermak
- Faculty of Mathematics and Physics, Department of Condensed Matter Physics, Charles University, Ke Karlovu 5, 121 16 Praha, Czech Republic
| | - A Schneidewind
- Jülich Centre for Neutron Science (JCNS) at Heinz Maier-Leibnitz Zentrum (MLZ), Forschungszentrum Jülich GmbH, Lichtenbergstrasse 1, 85748 Garching, Germany
| | - E Faulhaber
- Heinz Maier-Leibnitz Zentrum (MLZ), Technische Universität München, Lichtenbergstrasse 1, 85748 Garching, Germany
| | - J-M Mignot
- Laboratoire Léon Brillouin (CEA-CNRS), CEA Saclay, F-91911 Gif-sur-Yvette, France
| | - W J Duncan
- Department of Physics, Royal Holloway, University of London, Egham TW20 0EX, United Kingdom
| | - A Neubauer
- Physik Department E21, Technische Universität München, 85748 Garching, Germany
| | - C Pfleiderer
- Physik Department E21, Technische Universität München, 85748 Garching, Germany
| | - F M Grosche
- Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, United Kingdom
| |
Collapse
|
23
|
Zhong Z, Hasnah M, Broadbent A, Dooryhee E, Lucas M. Phase-space matching between bent Laue and flat Bragg crystals. J Synchrotron Radiat 2019; 26:1917-1923. [PMID: 31721734 DOI: 10.1107/s1600577519010774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Accepted: 08/01/2019] [Indexed: 06/10/2023]
Abstract
Through phase-space analysis of Dumond diagrams for a flat Bragg crystal, a single bent Laue crystal and a monochromator consisting of double-bent Laue crystals, this work shows that it is possible to match the flat Bragg crystal to both the single-crystal and double-crystal Laue monochromators. The matched system has the advantage that the phase space of the bent crystal's output beam is much larger than that of the flat crystal, making the combined system stable. Here it is suggested that such a matched system can be used at synchrotron facilities to realize X-ray dark-field imaging, analyzer-based imaging and diffraction-enhanced imaging at beamlines using double-Laue monochromators.
Collapse
Affiliation(s)
- Z Zhong
- National Syncrhrotron Light Source II, Brookhaven National Laboratory, Upton, NY 11973, USA
| | - M Hasnah
- Department of Mathematics, Statistics and Physics, Qatar University, Al Jamiaa Street, Doha, Qatar
| | - A Broadbent
- National Syncrhrotron Light Source II, Brookhaven National Laboratory, Upton, NY 11973, USA
| | - E Dooryhee
- National Syncrhrotron Light Source II, Brookhaven National Laboratory, Upton, NY 11973, USA
| | - M Lucas
- National Syncrhrotron Light Source II, Brookhaven National Laboratory, Upton, NY 11973, USA
| |
Collapse
|
24
|
Biswas S, Dinh D, Lucas M, Duffy SJ, Brennan A, Liew D, Cox N, Neil C, Reid CM, Lefkovits J, Stub D. P2654Impact of cultural and linguistic diversity on ischaemic time and clinical outcomes in patients undergoing percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Healthcare providers worldwide increasingly must face the challenge of providing care to culturally and linguistically diverse patients who may have limited proficiency in the primary working language of the country they are in. This language discordance may lead to delayed treatment and worse outcomes. The impact of limited English proficiency (LEP), in a predominantly English-speaking country like Australia, on time to reperfusion and outcomes following PCI for STEMI has not been previously studied.
Objective
Among patients undergoing PCI for STEMI, to compare baseline and procedural characteristics, time to reperfusion, and 30-day clinical outcomes in patients with LEP, compared to their English-proficient counterparts.
Method
We prospectively collected data on 7,721 patients undergoing PCI for STEMI between January 2013 and December 2017 who were enrolled in the state-wide multi-centre Victorian Cardiac Outcomes Registry. Data linkage to Department of Health administrative datasets was used to identify patients' primary spoken language. Patients who identified a language other than English as their primary spoken language were classified as having LEP. Patients' postcodes were used to identify socioeconomic status through Australian Government census data. The primary endpoint was 30-day major adverse cardiovascular events (MACE)
Results
Of the 7,721 patients included, 568 (7.4%) had LEP. Patients with LEP were more likely to be older, female, diabetic, have lower socioeconomic status and have severe renal impairment (all p<0.02). They were also more likely to present to a non-PCI capable hospital (p<0.001). Among primary PCI patients (n=5,385), symptom-to-balloon time was longer in the LEP group (237 [IQR 158–429] vs. 195 [IQR 141–326] minutes, p<0.001), driven mostly by longer symptom-to-door times (STDT) (150 [IQR 90–276] vs. 114 [IQR 75–215] minutes, p<0.001). LEP patients were also less likely to have a STDT≥120 minutes (48.8% vs. 41.7%, p-0.004). Patients with LEP had higher 30-day mortality (8.8% vs. 6.5%, p=0.04) and MACE (11.8 vs. 9.1%, p=0.04). They were also more likely to have severe left ventricular (LV) dysfunction post-STEMI (11.2% vs. 8.4%, p=0.003) and heart failure readmissions within 30 days of PCI (5.2% vs. 2.0%, p<0.001). On multivariate analysis, LEP was not an independent predictor of 30-day MACE (OR 1.27, 95% CI 0.82–1.95), but was an independent predictor of STDT≥120 minutes (OR 1.24, 95% CI 1.02–1.52).
Comparison of reperfusion times
Conclusion
Limited English-proficient patients with STEMI undergoing PCI tend to present later than their English-proficient counterparts and are more likely to have severe LV dysfunction and heart failure readmissions. LEP is an independent predictor of prolonged STDT but not 30-day MACE. This suggests that more effort needs to be placed in providing education in different languages to culturally and linguistically diverse patients, to encourage early presentation in the setting of STEMI.
Collapse
Affiliation(s)
- S Biswas
- The Alfred Hospital, Melbourne, Australia
| | - D Dinh
- Monash University, Melbourne, Australia
| | - M Lucas
- Monash University, Melbourne, Australia
| | - S J Duffy
- The Alfred Hospital, Melbourne, Australia
| | - A Brennan
- Monash University, Melbourne, Australia
| | - D Liew
- Monash University, Melbourne, Australia
| | - N Cox
- Western Health, Melbourne, Australia
| | - C Neil
- Western Health, Melbourne, Australia
| | - C M Reid
- Monash University, Melbourne, Australia
| | - J Lefkovits
- Royal Melbourne Hospital, Melbourne, Australia
| | - D Stub
- The Alfred Hospital, Melbourne, Australia
| |
Collapse
|
25
|
Sommerfield DL, Lucas M, Schilling A, Drake-Brockman TFE, Sommerfield A, Arnold A, von Ungern-Sternberg BS. Propofol use in children with allergies to egg, peanut, soybean or other legumes. Anaesthesia 2019; 74:1252-1259. [PMID: 31077340 DOI: 10.1111/anae.14693] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/06/2019] [Indexed: 12/13/2022]
Abstract
Propofol is the most commonly administered intravenous agent for anaesthesia in children. However, there are concerns that the emulsified preparation may not be safe in children with an allergy to egg, peanut, soybean or other legumes. We conducted a retrospective study of children with immunologically confirmed egg, peanut, soybean or legume allergy and who underwent general anaesthesia at Princess Margaret Hospital for Children between 2005 and 2015. We extracted details regarding allergy diagnosis, each anaesthetic administered and any adverse events or signs of an allergic reaction in the peri-operative period. A convenience sample of patients without any known food allergies was identified from our prospective anaesthesia research database and acted as a control group. We identified 304 food-allergic children and 649 procedures where propofol was administered. Of these, 201 (66%) had an egg allergy, 226 (74%) had a peanut allergy, 28 (9%) had a soybean allergy and 12 (4%) had a legume allergy. These were compared with 892 allergy-free patients who were exposed to propofol. In 10 (3%) allergy patients and 124 (14%) allergy-free patients, criteria for a possible allergic reaction were met. In nine of the food-allergic children and in all the controls valid non-allergic explanations for the clinical symptoms were found. One likely mild allergic reaction was experienced by a child with a previous history of intralipid allergy. We conclude that genuine serious allergic reaction to propofol is rare and is not reliably predicted by a history of food allergy.
Collapse
Affiliation(s)
- D L Sommerfield
- Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, WA, Australia
- Medical School, The University of Western Australia, Perth, WA, Australia
| | - M Lucas
- Medical School, The University of Western Australia, Perth, WA, Australia
- Department of Paediatric Clinical Immunology, Perth Children's Hospital, Perth, WA, Australia
| | - A Schilling
- Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, WA, Australia
- Medical School, The University of Western Australia, Perth, WA, Australia
| | - T F E Drake-Brockman
- Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, WA, Australia
- Medical School, The University of Western Australia, Perth, WA, Australia
| | - A Sommerfield
- Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, WA, Australia
- Telethon Kids Institute, Perth, WA, Australia
| | - A Arnold
- Department of Paediatric Clinical Immunology, Perth Children's Hospital, Perth, WA, Australia
| | - B S von Ungern-Sternberg
- Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, WA, Australia
- Medical School, The University of Western Australia, Perth, WA, Australia
- Telethon Kids Institute, Perth, WA, Australia
| |
Collapse
|
26
|
Patel S, Anzilotti C, Lucas M, Moore N, Chapel H. Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies? Clin Exp Immunol 2019; 198:212-223. [PMID: 31216049 DOI: 10.1111/cei.13343] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/14/2019] [Indexed: 12/30/2022] Open
Abstract
Various reports of disease-related lung pathologies in common variable immunodeficiency disorder (CVID) patients have been published, with differing histological and high-resolution computed tomography (HRCT) findings. Data were extracted from the validated Oxford Primary Immune Deficiencies Database (PID) database (1986-2016) on adult, sporadic CVID patients with suspected interstitial lung disease (ILD). Histology of lung biopsies was studied in relation to length of follow-up, clinical outcomes, HRCT findings and chest symptoms, to look for evidence for different pathological processes. Twenty-nine CVID patients with lung histology and/or radiological evidence of ILD were followed. After exclusions, lung biopsies from 16 patients were reanalysed for ILD. There were no well-formed granulomata, even though 10 patients had systemic, biopsy-proven granulomata in other organs. Lymphocytic infiltration without recognizable histological pattern was the most common finding, usually with another feature. On immunochemistry (n = 5), lymphocytic infiltration was due to T cells (CD4 or CD8). Only one patient showed B cell follicles with germinal centres. Interstitial inflammation was common; only four of 11 such biopsies also showed interstitial fibrosis. Outcomes were variable and not related to histology, suggesting possible different pathologies. The frequent nodules on HRCT were not correlated with histology, as there were no well-formed granulomata. Five patients were asymptomatic, so it is essential for all patients to undergo HRCT, and to biopsy if abnormal HRCT findings are seen. Internationally standardized pathology and immunochemical data are needed for longitudinal studies to determine the precise pathologies and prognoses in this severe complication of CVIDs, so that appropriate therapies may be found.
Collapse
Affiliation(s)
- S Patel
- Primary Immunodeficiency Unit, Department of Experimental Medicine, Nuffield Department of Medicine, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford, UK.,Department of Clinical Immunology, Oxford University Hospitals, John Radcliffe Site, Oxford, UK
| | - C Anzilotti
- Primary Immunodeficiency Unit, Department of Experimental Medicine, Nuffield Department of Medicine, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford, UK.,Department of Clinical Immunology, Oxford University Hospitals, John Radcliffe Site, Oxford, UK
| | - M Lucas
- Primary Immunodeficiency Unit, Department of Experimental Medicine, Nuffield Department of Medicine, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford, UK
| | - N Moore
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - H Chapel
- Primary Immunodeficiency Unit, Department of Experimental Medicine, Nuffield Department of Medicine, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford, UK.,Department of Clinical Immunology, Oxford University Hospitals, John Radcliffe Site, Oxford, UK.,Nuffield Department of Medicine, University of Oxford, Oxford, UK
| |
Collapse
|
27
|
Eccleston D, Cehic D, Lucas M, Worthley S. Long-term Trends in Coronary Risk Factor Prevalence and Adherence to Guideline Therapies in Australians with Coronary Heart Disease: 9-year Comparison with European Outcomes. Heart Lung Circ 2019. [DOI: 10.1016/j.hlc.2019.06.546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
28
|
Becker-Leckrone M, Lucas M, Start K, Zwarenstein C, One A, Merriwether SR, Milliken A, Moyer J, Teti SL, K A, Lawrence M, Odell R, Grinspoon P, Stuckenschneider E, Ballard E, Anderson J. Narrative Symposium: Living with Chronic Pain in the Midst of the Opioid Crisis. Narrat Inq Bioeth 2019; 8:193-224. [PMID: 30595576 DOI: 10.1353/nib.2018.0056] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
29
|
Biswas S, Dinh D, Lucas M, Duffy S, Brennan A, Liew D, Cox N, Neil C, Reid C, Lefkovits J, Stub D. Impact of Limited English Proficiency on Ischaemic Time and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction. Heart Lung Circ 2019. [DOI: 10.1016/j.hlc.2019.06.630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
30
|
Rivera S, Petit C, Martin AN, Cacicedo J, Leaman O, Rosselot MCA, Lazaryan A, Akperov K, Sinaika V, Monestel R, Fröbe A, Kevlishvili G, Stojkovski I, Magsar B, Corovic M, Mahmood H, Alauddin Z, Barriga O, Lucas M, Palmu M, Zubizarreta E, Hopkins K, Eriksen J. Long-term impact on contouring skills achieved by online learning. An ESTRO-FALCON-IAEA study. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
31
|
Li X, Lucas M, Harkness P. Full and Half-Wavelength Ultrasonic Percussive Drills. IEEE Trans Ultrason Ferroelectr Freq Control 2018; 65:2150-2159. [PMID: 30176586 DOI: 10.1109/tuffc.2018.2867535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Ultrasonic percussive drills are a leading technology for small rock drilling applications where power and weight-on-bit are at a premium. The concept uses ultrasonic vibrations to excite an oscillatory motion in a free-mass, which then delivers impulsive blows to a drilling-bit. This is a relatively complex dynamic problem involving the transducer, the free-mass, the drilling-bit and, to a certain extent, the rock surface itself. This paper examines the performance of a full-wavelength transducer compared to a half-wavelength system, which may be more attractive due to mass and dimensional drivers. To compare the two approaches, 3-D finite-element models of the ultrasonic percussive stacks using full and half-wavelength ultrasonic transducers are created to assess delivered impulse at similar power settings. In addition, impact-induced stress levels are evaluated to optimize the design of drill tools at a range of internal spring rates before, finally, experimental drilling is conducted. The results suggest that full-wavelength systems will yield much more effective impulse but, interestingly, their actual drilling performance was only marginally better than half-wavelength equivalents.
Collapse
|
32
|
Vos DRN, Jansen I, Lucas M, Paine MRL, de Boer OJ, Meijer SL, Savci-Heijink CD, Marquering HA, de Bruin DM, Heeren RMA, Ellis SR, Balluff B. Strategies for managing multi-patient 3D mass spectrometry imaging data. J Proteomics 2018; 193:184-191. [PMID: 30343012 DOI: 10.1016/j.jprot.2018.10.008] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2018] [Revised: 09/26/2018] [Accepted: 10/17/2018] [Indexed: 01/30/2023]
Abstract
Mass spectrometry imaging (MSI) has emerged as a powerful tool in biomedical research to reveal the localization of a broad scale of compounds ranging from metabolites to proteins in diseased tissues, such as malignant tumors. MSI is most commonly used for the two-dimensional imaging of tissues from multiple patients or for the three-dimensional (3D) imaging of tissue from a single patient. These applications are potentially introducing a sampling bias on a sample or patient level, respectively. The aim of this study is therefore to investigate the consequences of sampling bias on sample representativeness and on the precision of biomarker discovery for histological grading of human bladder cancers by MSI. We therefore submitted formalin-fixed paraffin-embedded tissues from 14 bladder cancer patients with varying histological grades to 3D analysis by matrix-assisted laser desorption/ionization (MALDI) MSI. We found that, after removing 20% of the data based on novel outlier detection routines for 3D-MSI data based on the evaluation of digestion efficacy and z-directed regression, on average 33% of a sample has to be measured in order to obtain sufficient coverage of the existing biological variance within a tissue sample. SIGNIFICANCE: In this study, 3D MALDI-MSI is applied for the first time on a cohort of bladder cancer patients using formalin-fixed paraffin-embedded (FFPE) tissue of bladder cancer resections. This work portrays the reproducibility that can be achieved when employing an optimized sample preparation and subsequent data evaluation approach. Our data shows the influence of sampling bias on the variability of the results, especially for a small patient cohort. Furthermore, the presented data analysis workflow can be used by others as a 3D FFPE data-analysis pipeline working on multi-patient 3D-MSI studies.
Collapse
Affiliation(s)
- D R N Vos
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Maastricht University, 6229 ER Maastricht, the Netherlands
| | - I Jansen
- Department of Urology, Department of Biomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - M Lucas
- Department of Biomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - M R L Paine
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Maastricht University, 6229 ER Maastricht, the Netherlands
| | - O J de Boer
- Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - S L Meijer
- Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - C D Savci-Heijink
- Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - H A Marquering
- Department of Biomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - D M de Bruin
- Department of Urology, Department of Biomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - R M A Heeren
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Maastricht University, 6229 ER Maastricht, the Netherlands
| | - S R Ellis
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Maastricht University, 6229 ER Maastricht, the Netherlands
| | - B Balluff
- The Maastricht Multimodal Molecular Imaging Institute (M4I), Maastricht University, 6229 ER Maastricht, the Netherlands.
| |
Collapse
|
33
|
Rogers KA, Huang Y, Ruppert AS, Awan FT, Heerema NA, Hoffman C, Lozanski G, Maddocks KJ, Moran ME, Reid MA, Lucas M, Woyach JA, Whitlow WT, Jones JA, Byrd JC. Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia. Blood 2018; 132:1568-1572. [PMID: 30111609 PMCID: PMC6182267 DOI: 10.1182/blood-2018-05-853564] [Citation(s) in RCA: 86] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2018] [Accepted: 08/07/2018] [Indexed: 01/01/2023] Open
Abstract
Targeted therapies including the engineered afucosylated anti-CD20 monoclonal antibody obinutuzumab, Bruton's tyrosine kinase inhibitor ibrutinib, and B-cell lymphoma protein 2 inhibitor venetoclax have demonstrated significant clinical activity in chronic lymphocytic leukemia (CLL) and, based on their complementary mechanisms, are ideal for combination. However, combining venetoclax with other active agents raises safety concerns, as it may increase the risk for tumor lysis syndrome. To minimize this risk, we designed and implemented a fixed-duration regimen using sequentially administered obinutuzumab followed by ibrutinib (cycle 2) and venetoclax (cycle 3), for a total of fourteen 28-day cycles. This phase 1b study included 12 patients with relapsed or refractory CLL. We tested 3 dose levels of venetoclax and identified the doses of all 3 agents approved by the US Food and Drug Administration for use in the combination. Adverse events were consistent with known toxicities of the individual agents, with hematologic adverse events being most frequent. No clinically significant tumor lysis syndrome occurred. The overall response rate was 92% (95% confidence interval, 62%-100%), with 42% (5/12) achieving a complete remission or complete remission with incomplete marrow recovery. There were 6 patients with no detectable CLL in both the blood and bone marrow at the end of treatment. We found this regimen to be safe and tolerable in CLL, and capable of inducing deep responses, justifying future study in our ongoing phase 2 cohorts of relapsed or refractory and treatment-naive patients, as well as larger phase 3 trials currently in planning. This trial was registered at www.clinicaltrials.gov as #NCT02427451.
Collapse
MESH Headings
- Adenine/analogs & derivatives
- Adult
- Aged
- Antibodies, Monoclonal, Humanized/administration & dosage
- Antibodies, Monoclonal, Humanized/adverse effects
- Antibodies, Monoclonal, Humanized/therapeutic use
- Antineoplastic Agents/administration & dosage
- Antineoplastic Agents/adverse effects
- Antineoplastic Agents/therapeutic use
- Antineoplastic Combined Chemotherapy Protocols/administration & dosage
- Antineoplastic Combined Chemotherapy Protocols/adverse effects
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Bridged Bicyclo Compounds, Heterocyclic/administration & dosage
- Bridged Bicyclo Compounds, Heterocyclic/adverse effects
- Bridged Bicyclo Compounds, Heterocyclic/therapeutic use
- Drug Administration Schedule
- Female
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local/drug therapy
- Piperidines
- Pyrazoles/administration & dosage
- Pyrazoles/adverse effects
- Pyrazoles/therapeutic use
- Pyrimidines/administration & dosage
- Pyrimidines/adverse effects
- Pyrimidines/therapeutic use
- Sulfonamides/administration & dosage
- Sulfonamides/adverse effects
- Sulfonamides/therapeutic use
Collapse
Affiliation(s)
- Kerry A Rogers
- Division of Hematology
- The Ohio State University Comprehensive Cancer Center
| | | | | | | | | | | | | | | | | | | | | | - Jennifer A Woyach
- Division of Hematology
- The Ohio State University Comprehensive Cancer Center
| | | | | | - John C Byrd
- Division of Hematology
- The Ohio State University Comprehensive Cancer Center
- Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH
| |
Collapse
|
34
|
Lucas M, Wagshul M, Izzetoglu M, Holtzer R. A - 19Moderating Effect of White Matter Integrity on Brain Activation During Dual-Task Walking in Older Adults. Arch Clin Neuropsychol 2018. [DOI: 10.1093/arclin/acy061.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Vermeulin T, Lucas M, Lahbib H, Froment L, Czernichow P, Josset V, Jusot F, Di Fiore F, Launoy G, Merle V. Conformité du délai d’initiation de la chimiothérapie adjuvante pour cancer du côlon : élaboration d’un indicateur qualité à partir du PMSI. ONCOLOGIE 2018. [DOI: 10.3166/onco-2018-0014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
36
|
Lucas M, Gross R, Jooste V, Touchais S, Gadbled G, Buffenoir K, Hamel O, Perrouin-Verbe B. Outcomes of equinus/varus foot surgery in patients with spastic paresis: A retrospective study on 126 patients. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
37
|
Palles C, Fotheringham S, Chegwidden L, Lucas M, Mozolowski G, Tomlinson I, Kerr D. An evaluation of the clinical utility of a panel of variants in DPYD and ENOSF1 for predicting common capecitabine related toxicities. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.212] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Kohonen-Corish M, Benthani F, Herrmann D, Phuong T, Currey N, Lucas M, Allam A, Al-Sohaily S, Warusavitarne J, Timpson P. PO-168 Loss of the MCC gene expression promotes invasiveness of colon cancer cells. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
39
|
Sigmund A, Huang Y, Ruppert AS, Ny F, Lucas M, Chase W, Maddocks KJ, Rogers KA, Jaglowski SM, Andritsos LA, Awan FT, Grever MR, Byrd JC, Woyach JA. Depth of response and progression free survival in CLL patients on ibrutinib. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.7514] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Audrey Sigmund
- The Ohio State University, Department of Internal Medicine, Columbus, OH
| | - Ying Huang
- The Ohio State University, Division of Hematology, Columbus, OH
| | - Amy S. Ruppert
- The Ohio State University, Division of Hematology, Columbus, OH
| | - Fan Ny
- The Ohio State University, Division of Hematology, Columbus, OH
| | - Margaret Lucas
- The Ohio State University, Division of Hematology, Columbus, OH
| | - Weihong Chase
- The Ohio State University, Division of Hematology, Columbus, OH
| | | | | | | | | | | | | | - John C. Byrd
- The Ohio State University, Division of Hematology, Columbus, OH
| | | |
Collapse
|
40
|
Feeney A, Lucas M. A Comparison of Two Configurations for a Dual-Resonance Cymbal Transducer. IEEE Trans Ultrason Ferroelectr Freq Control 2018; 65:489-496. [PMID: 29505415 DOI: 10.1109/tuffc.2018.2793310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The ability to design tuned ultrasonic devices that can be operated in the same mode at two different frequencies has the potential to benefit a range of applications, such as surgical cutting procedures where the penetration through soft then hard tissues could be enhanced by switching the operating frequency. The cymbal transducer has recently been adapted to form a prototype ultrasonic surgical cutting device that operates at a single frequency. In this paper, two different methods of configuring a dual-resonance cymbal transducer are detailed. The first approach relies on transducer fabrication using different metals for the two endcaps, thereby forming a dual-resonance transducer. The second employs transducer endcaps composed from a shape memory alloy, superelastic Nitinol. The resonance frequency of the Nitinol transducer depends on the phase microstructure of the material, switchable through the temperature or stress dependence of the Nitinol endcaps. The vibration response of each transducer is measured through electrical impedance measurements and laser Doppler vibrometry, and finite-element analysis is used to show the sensitivity of transducer modal response to the fabrication processes. Through this paper, two viable dual-resonance cymbal transducers are designed and characterized and compared to illustrate the advantages and disadvantages of the two different approaches.
Collapse
|
41
|
Lucas M. My Chronic Pain is Like My Pit Bull: Very Strong and Won't Leave My Side. Narrat Inq Bioeth 2018; 8:196-198. [PMID: 30595578 DOI: 10.1353/nib.2018.0060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
|
42
|
Andrés RR, Acosta VM, Lucas M, Riera E. Modal analysis and nonlinear characterization of an airborne power ultrasonic transducer with rectangular plate radiator. Ultrasonics 2018; 82:345-356. [PMID: 28985624 DOI: 10.1016/j.ultras.2017.09.017] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Revised: 07/11/2017] [Accepted: 09/24/2017] [Indexed: 06/07/2023]
Abstract
Some industrial processes like particle agglomeration or food dehydration among others can be enhanced by the use of power ultrasonic technologies. These technologies are based on an airborne power ultrasonic transducer (APUT) constituted by a pre-stressed Langevin-type transducer, a mechanical amplifier and an extensive plate radiator. In order to produce the desired effects in industrial processing, the transducer has to vibrate in an extensional mode driving an extensive radiator in the desired flexural mode with high amplitude displacements. Due to the generation of these high amplitude displacements in the radiator surfaces, non-linear effects like frequency shifts, hysteresis or modal interactions, among others, may be produced in the transducer behavior. When any nonlinear effect appears, when applying power, the stability and efficiency of this ultrasonic technology decreases, and the transducer may be damaged depending on the excitation power level and the nature of the nonlinearity. In this paper, an APUT with flat rectangular radiator is presented, as the active part of an innovative system with stepped reflectors. The nonlinear behavior of the APUT has been characterized numerically and experimentally in case of the modal analysis and experimentally in the case of dynamic analysis. According to the results obtained after the experiments, no modal interactions are expected, nor do other nonlinear effects.
Collapse
Affiliation(s)
- R R Andrés
- Departamento de Sensores y Sistemas Ultrasónicos (DSSU), ITEFI, CSIC, Serrano 144 28006, Madrid, Spain.
| | - V M Acosta
- Departamento de Sensores y Sistemas Ultrasónicos (DSSU), ITEFI, CSIC, Serrano 144 28006, Madrid, Spain
| | - M Lucas
- School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK
| | - E Riera
- Departamento de Sensores y Sistemas Ultrasónicos (DSSU), ITEFI, CSIC, Serrano 144 28006, Madrid, Spain
| |
Collapse
|
43
|
Ruiz J, Kaiser AS, Lucas M. Experimental determination of drift and PM 10 cooling tower emissions: Influence of components and operating conditions. Environ Pollut 2017; 230:422-431. [PMID: 28675852 DOI: 10.1016/j.envpol.2017.06.073] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2017] [Revised: 06/19/2017] [Accepted: 06/21/2017] [Indexed: 06/07/2023]
Abstract
Cooling tower emissions have become an increasingly common hazard to the environment (air polluting, ice formation and salts deposition) and to the health (Legionella disease) in the last decades. Several environmental policies have emerged in recent years limiting cooling tower emissions but they have not prevented an increasing intensity of outbreaks. Since the level of emissions depends mainly on cooling tower component design and the operating conditions, this paper deals with an experimental investigation of the amount of emissions, drift and PM10, emitted by a cooling tower with different configurations (drift eliminators and distribution systems) and working under several operating conditions. This objective is met by the measurement of cooling tower source emission parameters by means of the sensitive paper technique. Secondary objectives were to contextualize the observed emission rates according to international regulations. Our measurements showed that the drift rates included in the relevant international standards are significantly higher than the obtained results (an average of 100 times higher) and hence, the environmental problems may occur. Therefore, a revision of the standards is recommended with the aim of reducing the environmental and human health impact. By changing the operating conditions and the distribution system, emissions can be reduced by 52.03% and 82% on average. In the case of drift eliminators, the difference ranges from 18.18% to 98.43% on average. As the emissions level is clearly influenced by operating conditions and components, regulation tests should be referred to default conditions. Finally, guidelines to perform emission tests and a selection criterion of components and conditions for the tested cooling tower are proposed.
Collapse
Affiliation(s)
- J Ruiz
- Departamento de Ingeniería Mecánica y Energía, Universidad Miguel Hernández, Avda. de la Universidad, s/n, 03202 Elche, Spain.
| | - A S Kaiser
- Departamento de Ingeniería Térmica y de Fluidos, Universidad Politécnica de Cartagena (Campus Muralla del Mar), Dr. Fleming, s/n, 30202 Cartagena, Spain
| | - M Lucas
- Departamento de Ingeniería Mecánica y Energía, Universidad Miguel Hernández, Avda. de la Universidad, s/n, 03202 Elche, Spain
| |
Collapse
|
44
|
Mondejar R, Lucas M. Molecular diagnosis in cerebral cavernous malformations. Neurología (English Edition) 2017. [DOI: 10.1016/j.nrleng.2015.07.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
45
|
Horgan L, Knezevic B, Klinken E, Clarke R, Sadleir P, Platt P, Bundell C, Lucas M. P19: JUST A SPOONFUL OF COUGH SYRUP: A CASE OF PHOLCODINE HYPERSENSITIVITY. Intern Med J 2017. [DOI: 10.1111/imj.19_13578] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- L Horgan
- Department of Immunology, Sir Charles Gairdner Hospital; Perth Australia
| | - B Knezevic
- Department of Immunology, Sir Charles Gairdner Hospital; Perth Australia
| | - E Klinken
- Department of Immunology, Sir Charles Gairdner Hospital; Perth Australia
| | - R Clarke
- Department of Anaesthetics, Sir Charles Gairdner Hospital; Perth Australia
| | - P Sadleir
- Department of Anaesthetics, Sir Charles Gairdner Hospital; Perth Australia
| | - P Platt
- Department of Anaesthetics, Sir Charles Gairdner Hospital; Perth Australia
| | - C Bundell
- Department of Immunology, Sir Charles Gairdner Hospital; Perth Australia
| | - M Lucas
- Department of Immunology, Sir Charles Gairdner Hospital; Perth Australia
| |
Collapse
|
46
|
Rueter K, Ta B, Bear N, Borland ML, Lucas M, Prescott SL. P49: ARE TIME-TREND DATA SIGNIFICANTLY INFLUENCED BY IMPROVEMENT IN DIAGNOSING ANAPHYLAXIS OVER TIME? Intern Med J 2017. [DOI: 10.1111/imj.49_13578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- K Rueter
- School of Paediatrics and Child Health; University of Western Australia; Australia
- Department of Paediatric Immunology, Princess Margaret Hospital for Children; Perth Australia
- Department of Paediatric Emergency Medicine, Princess Margaret Hospital for Children; Perth Australia
| | - B Ta
- Department of Paediatric Emergency Medicine, Princess Margaret Hospital for Children; Perth Australia
| | - N Bear
- School of Paediatrics and Child Health; University of Western Australia; Australia
- Telethon Kids Institute; University of Western Australia; Australia
| | - ML Borland
- School of Paediatrics and Child Health; University of Western Australia; Australia
- Department of Paediatric Emergency Medicine, Princess Margaret Hospital for Children; Perth Australia
| | - M Lucas
- Department of Paediatric Immunology, Princess Margaret Hospital for Children; Perth Australia
- School of Medicine and Pharmacology and School of Pathology and Laboratory Medicine; University of Western Australia; Australia
- Institute for Immunology and Infectious Diseases; Murdoch University; Perth Australia
- Department of Immunology, Pathwest and Sir Charles Gardiner Hospital; Perth Australia
| | - SL Prescott
- School of Paediatrics and Child Health; University of Western Australia; Australia
- Department of Paediatric Immunology, Princess Margaret Hospital for Children; Perth Australia
- Department of Paediatric Emergency Medicine, Princess Margaret Hospital for Children; Perth Australia
| |
Collapse
|
47
|
Braconnier L, Arnold A, Sommerfield A, Slevin L, Sommerfield D, Rueter K, von Ungern-Sternberg BS, Lucas M. P12: THE RATE OF ATOPIC DISEASES IN CHILDREN WITH REPORTED ANTIBIOTIC ALLERGIES. Intern Med J 2017. [DOI: 10.1111/imj.12_13578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- L Braconnier
- School of Medicine and Pharmacology; University of Western Australia; Australia
- Immunology Department, Princess Margaret Hospital; Perth Australia
| | - A Arnold
- Immunology Department, Princess Margaret Hospital; Perth Australia
| | - A Sommerfield
- Department of Anaesthesia and Pain Management, Princess Margaret Hospital; Perth Australia
- Telethon Kids Institute; Perth Australia
| | - L Slevin
- Department of Anaesthesia and Pain Management, Princess Margaret Hospital; Perth Australia
- Telethon Kids Institute; Perth Australia
| | - D Sommerfield
- Department of Anaesthesia and Pain Management, Princess Margaret Hospital; Perth Australia
| | - K Rueter
- Immunology Department, Princess Margaret Hospital; Perth Australia
- School of Paediatrics and Child Health; University of Western Australia; Perth Australia
- Immunology Department, PathWest Laboratory Medicine; WAPerth Australia
| | - BS von Ungern-Sternberg
- School of Medicine and Pharmacology; University of Western Australia; Australia
- Department of Anaesthesia and Pain Management, Princess Margaret Hospital; Perth Australia
- Telethon Kids Institute; Perth Australia
| | - M Lucas
- School of Medicine and Pharmacology; University of Western Australia; Australia
- Immunology Department, Princess Margaret Hospital; Perth Australia
- Immunology Department, PathWest Laboratory Medicine; WAPerth Australia
- School of Pathology and Laboratory Medicine; University of Western Australia; Australia
- Institute for Immunology and Infectious Diseases; Murdoch University; Australia. Immunology Department, Sir Charles Gairdner Hospital; Perth Australia
| |
Collapse
|
48
|
Arnold A, Jeelall Y, Braconnaire L, Sommerfield A, Bundell C, Sommerfield D, Slevin L, Rueter K, von Ungern-Sternberg BS, Lucas M. P8: THE EFFICACY OF SKIN TESTING, SPECIFIC IgE AND BASAL ACTIVATION TESTING IN PREDICTING THE OUTCOME OF ORAL PROVOCATION CHALLENGES IN CHILDREN WITH SUSPECTED BETA-LACTAM ALLERGY. Intern Med J 2017. [DOI: 10.1111/imj.8_13578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A Arnold
- Immunology Department; Princess Margaret Hospital; Perth Australia
| | - Y Jeelall
- School of Medicine and Pharmacology; University of Western Australia; Australia
| | - L Braconnaire
- School of Medicine and Pharmacology; University of Western Australia; Australia
| | | | - C Bundell
- Telethon Kids Institute; Perth Australia
| | - D Sommerfield
- Department of Anaesthesia and Pain Management; Princess Margaret Hospital; Perth Australia
| | - L Slevin
- Telethon Kids Institute; Perth Australia
| | - K Rueter
- Immunology Department; Princess Margaret Hospital; Perth Australia
- School of Medicine and Pharmacology; University of Western Australia; Australia
- Department of Clinical Research and Education; Princess Margaret Hospital; Perth Australia
| | - BS von Ungern-Sternberg
- Department of Anaesthesia and Pain Management; Princess Margaret Hospital; Perth Australia
- School of Medicine and Pharmacology; University of Western Australia; Australia
| | - M Lucas
- Immunology Department; Princess Margaret Hospital; Perth Australia
- School of Medicine and Pharmacology; University of Western Australia; Australia
- Immunology Department; PathWest Laboratory Medicine WA; Perth Australia
- School of Biomedical Sciences; University of Western Australia; Australia
- Immunology Department; Sir Charles Gairdner Hospital; Perth Australia. Institute for Immunology and Infectious Diseases; Murdoch University; Perth Australia
| |
Collapse
|
49
|
Knezevic B, Sprigg D, Seet J, Trevenen M, Trubiano J, Smith W, Jeelall Y, Vale S, Loh R, McLean-Tooke A, Lucas M. The revolving door: antibiotic allergy labelling in a tertiary care centre. Intern Med J 2017; 46:1276-1283. [PMID: 27530619 DOI: 10.1111/imj.13223] [Citation(s) in RCA: 43] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2016] [Revised: 06/13/2016] [Accepted: 07/18/2016] [Indexed: 11/27/2022]
Abstract
BACKGROUND Patients frequently report antibiotic allergies; however, only 10% of labelled patients have a true allergy. AIM We investigated the documentation of antibiotic 'allergy' labels (AAL) and the effect of labelling on clinical outcomes, in a West Australian adult tertiary hospital. METHODS Retrospective cross-sectional analysis of patients captured in the 2013 and 2014 National Antimicrobial Prescribing Surveys was carried out. Data were collected on documented antibiotic adverse drug reactions, antibiotic cost, prescribing appropriateness, prevalence of multi-drug resistant organisms, length of stay, intensive care admission and readmissions. RESULTS Of the 687 patients surveyed, 278 (40%) were aged 70 or above, 365 (53%) were male and 279 (41%) were prescribed antibiotics. AAL were recorded in 122 (18%) patients and the majority were penicillin labels (n = 87; 71%). Details of AAL were documented for 80 of 141 (57%) individual allergy labels, with 61 describing allergic symptoms. Patients with beta-lactam allergy labels received fewer penicillins (P = 0.0002) and more aminoglycosides (P = 0.043) and metronidazole (P = 0.021) than patients without beta-lactam labels. Five patients received an antibiotic that was contraindicated according to their allergy status. Patients with AAL had significantly more hospital readmissions within 4 weeks (P = 0.001) and 6 months (P = 0.025) of discharge, compared with unlabelled patients. The majority (81%) of readmitted labelled patients had major infections. CONCLUSIONS AAL are common, but poorly documented in hospital records. Patients with AAL are significantly more likely to require alternative antibiotics and hospital readmissions. There may be a role for antibiotic allergy delabelling to mitigate the clinical and economic burdens for patients with invalid allergy labels.
Collapse
Affiliation(s)
- B Knezevic
- Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.
| | - D Sprigg
- Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia
| | - J Seet
- Department of Research, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
| | - M Trevenen
- Department of Research, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.,Centre for Applied Statistics, University of Western Australia, Perth, Western Australia, Australia
| | - J Trubiano
- Department of Infectious Diseases, Austin Health, Melbourne, Victoria, Australia
| | - W Smith
- Department of Immunology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
| | - Y Jeelall
- School of Medicine and Pharmacology, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia
| | - S Vale
- Drug Allergy Working Party, Australasian Society of Clinical Immunology and Allergy, Sydney, New South Wales, Australia
| | - R Loh
- Department of Clinical Immunology, Princess Margaret Hospital, Perth, Western Australia, Australia.,Pathwest Laboratory, Queen Elizabeth II Campus, Perth, Western Australia, Australia
| | - A McLean-Tooke
- Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.,Pathwest Laboratory, Queen Elizabeth II Campus, Perth, Western Australia, Australia
| | - M Lucas
- Department of Clinical Immunology, Royal Perth Hospital, Perth, Western Australia, Australia.,Pathwest Laboratory, Queen Elizabeth II Campus, Perth, Western Australia, Australia.,Department of Clinical Immunology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.,Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Western Australia, Australia
| |
Collapse
|
50
|
Kalyon N, Hofmann K, Malter J, Lucas M, Claus P, Albert B. Catalytic activity of nanoscale borides: Co2B and Ni7B3 in the liquid-phase hydrogenation of citral. J Catal 2017. [DOI: 10.1016/j.jcat.2017.06.009] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|